Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples.
Saved in:
| Title: | Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples. |
|---|---|
| Authors: | Liu Y; Biogen, Cambridge, Massachusetts. Electronic address: christine.liu369@gmail.com., Yang M; Biogen, Cambridge, Massachusetts., Fraser K; Biogen, Cambridge, Massachusetts., Graham D; Biogen, Cambridge, Massachusetts., Weinreb PH; Biogen, Cambridge, Massachusetts., Weihofen A; Biogen, Cambridge, Massachusetts., Hirst WD; Biogen, Cambridge, Massachusetts., Cedarbaum JM; Biogen, Cambridge, Massachusetts., Pepinsky B; Biogen, Cambridge, Massachusetts. |
| Source: | The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2025 Jan; Vol. 392 (1), pp. 100003. Date of Electronic Publication: 2024 Nov 22. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1521-0103 |
|---|---|
| DOI: | 10.1124/jpet.124.002199 |
